Asthma study aims to better understand uncontrolled disease in daily life

NCT ID NCT06299306

Terminated Knowledge-focused Sponsor: AstraZeneca Source: ClinicalTrials.gov ↗

First seen Jun 26, 2026 · Last updated Jun 26, 2026

Summary

This study looked at adults with severe uncontrolled asthma in Germany to see how well their asthma was controlled over 12 months. Researchers used a simple questionnaire called AIRQ® to track symptoms, medication use, and doctor visits. The goal was to gather real-world information to help identify patients who need better care.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for ASTHMA, BRONCHIAL are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

asthma chronic asthma inherited susceptibility to asthma

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

ASTHMA, BRONCHIAL

Contacts and locations

Locations

Research Site

Berlin, Germany
Research Site

Blankenhein, Germany
Research Site

Bonn, Germany
Research Site

Fürstenwalde, Germany
Research Site

Gauting, Germany
Research Site

Weißenburg, Germany

More trials for these conditions

Other studies related to the condition(s) this trial covers.